Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.
about
Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopeciaThe dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depressionAssociation of Suicidality and Depression With 5α-Reductase Inhibitors.Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function.Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain.Emotional Consequences of Finasteride: Fool's Gold.An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.Research Brief: Self-Reports of a Constellation of Persistent Antiandrogenic, Estrogenic, Physical, and Psychological Effects of Finasteride Usage Among Men.5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases.Das Post-Finasterid-SyndromNeuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients
P2860
Q21089672-349E66E2-35D0-4034-9691-994822F42E77Q24564068-D5824C26-7B39-4E54-A260-67470B1D9D50Q34553657-B41C48D4-0CB4-4E2E-9327-7B7D9382410EQ37694089-5A5387E6-6BFB-4BD2-BEA7-12B441FC7F78Q38239520-F068B370-1CB3-49CB-99B7-8A2C13EC6531Q38955319-9D3C1A6D-FD78-4EAF-8AF5-F2559E2D3105Q47135249-867C17D3-A376-4806-ACBC-95AEA05356A7Q47596977-C19BBCCE-93FC-4EDF-9D0D-C656F68642F3Q47659689-2428BD59-3293-4A01-AC65-1D2F0E102C69Q47877573-B4B3C80D-85A5-4E27-AC71-AE47848FA37DQ48040556-B54C23DA-1C0D-44D8-BB97-9B45FA2B2593Q49971559-B7C311A5-C56C-4A3F-8D18-18BE5D1734AAQ55058331-864D4142-90F1-45AA-AF12-628CD704B806Q55364650-71C2F14F-2D7D-461D-99C7-0CA5963723F7Q56700760-1D5E52CE-A8BD-4567-9C04-28F1C5EDF725Q58874343-37F50CDF-A931-45F6-A7DC-3E01DB4EEFDB
P2860
Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@ast
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@en
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@nl
type
label
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@ast
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@en
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@nl
prefLabel
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@ast
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@en
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@nl
P2093
P50
P356
P1476
Neuroactive steroid levels are ...... ous/depressive symptomatology.
@en
P2093
Donatella Caruso
Donato Calabrese
Federico Abbiati
Roberto Cosimo Melcangi
P304
P356
10.1111/JSM.12269
P577
2013-07-24T00:00:00Z